| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05f797de40f3c87e7e0d0cacf6087afc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d92297fe0357aadf597e20931291c432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d69ecad3a579694ea7a8518bf0e7169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c682dcd1452394e0c1c442b3c784a76 |
| publicationDate |
2014-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201408299-A |
| titleOfInvention |
LAQUINIMOD formulation without alkalizing agent |
| abstract |
The present invention provides a stable pharmaceutical composition comprising a therapeutically effective amount of laquinimod, a quantity of a filler, and a quantity of a lubricant, wherein the stable pharmaceutical composition is free of an alkalizing agent or a redox agent. The invention also provides a method of preparing the stabilized pharmaceutical composition and a sealed package comprising the stabilized pharmaceutical composition. The invention further provides a method of treating a subject suffering from multiple forms of multiple sclerosis or ameliorating multiple sclerosis symptoms in an individual suffering from a form of multiple sclerosis, the method comprising administering to the individual a stable medicament as described herein combination. The invention further provides the use of a stable pharmaceutical composition as described herein for the treatment of an individual suffering from one form of multiple sclerosis or for alleviating multiple sclerosis symptoms in an individual suffering from one form of multiple sclerosis. |
| priorityDate |
2012-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |